4//SEC Filing
Bjarke Henric Bjorn 4
Accession 0001209191-22-052022
CIK 0001693011other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 8:00 AM ET
Size
5.0 KB
Accession
0001209191-22-052022
Insider Transaction Report
Form 4
Bjarke Henric Bjorn
See Remarks
Transactions
- Award
Common Stock
2022-09-30$2.28/sh+3,315$7,558→ 83,941 total
Footnotes (1)
- [F1]Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 1, 2022 through September 30, 2022. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the issuer's common stock on September 30, 2022.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001652179
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 8:00 AM ET
- Size
- 5.0 KB